Abba Medix ( http://www.abbamedix.com/ ) was founded in 2013 to capitalize on the dramatically changing rules governing medical marijuana production in Canada. On April 1, 2014, Health Canada eliminated the ability of the approximately 37,000 Canadians currently licensed to grow and possess medical marijuana for medicinal use on their own. Patients must now purchase product from commercially producing providers licensed by Health Canada. Although patients will still need appropriate documentation signed by a health care practitioner and must register with one of the commercial producers, the registered producer will now file the application on behalf of the patient to Health Canada. Abba Medix has made an application to Health Canada to become a commercial producer. ABBA intends to broaden its product offering including these products to provide a full menu of complementary product and service offerings in this sector also ABBA has the experience and expertise in the beverage market through principal shareholders and affiliates and plan to distribute and leverage this product offering through established distribution channels. Under the terms of the agreement, Abba has agreed to license fee based on a number of parameters; a portion of which has already been paid, to license its proprietary technologies where they will act as the Companys exclusive marketing agent in Canada and certain other countries. Dutch Gold Resources may elect to convert part of the outstanding license fee into equity in Abba Medix, in the event that the ABBAs shares become publicly traded. We are pleased that we have found a partner in Abba Medix. Their unique understanding of the Canadian MMJ market complements our initial marketing efforts in the United States.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/dutch-gold-executes-license-agreement-110000130.html

By admin